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In Rwanda, cardiovascular diseases (CVDs) ranked second of the most common 
cause of death in 2016.  CVD risk score tools have been recommended to 
identify people at high risk for management. 
Objective  
To assess the comparability of body mass index (BMI)-based and lipid-based 
CVD risk scores in Rwandan population.  
Methods 
Secondary analysis was conducted on 4185 study participants extracted from 
the dataset of Rwanda 2012-2013 non-communicable diseases risk factors 




survey. Individual CVD risk scores were calculated using both BMI-based and 
lipid-based algorithms, one at a time. Spearman rank’s coefficient and Cohen’s 
Kappa coefficient were used to compare the two tools.  
Results 
About 63.5% of participants were women. There was a significant positive 
correlation between BMI-based algorithm and lipid-based algorithm vis-à-vis a 
10-year CVD risk prediction (Spearman rank correlation coefficients > 0.90, 
p<0.001) considering either men, women or overall study participants. There 
was a moderate agreement between BMI-based and lipid-based algorithms vis-
à-vis CVD risk characterization, kappa = 0.52; p-value p<0.001 considering 
either overall study participants or men and kappa = 0.48; p-value p<0.001 
considering women.  
  
Conclusion 
The findings from this study suggest the use of BMI-based algorithm, a cost 
effective tool compared to lipid-based tool, can be alternatively used in 
resource-limited settings.   
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Globally, cardiovascular disease 
(CVD) accounts for 17.9 million 
deaths annually, representing 31% 
of all global deaths and this makes 
them (CVDs) to be at the first 
position of deaths globally.[1] About 
80% of all global CVD-related deaths 
occur in low- and middle-income 
countries (LMICs).[2] Sub-Saharan 
Africa (SSA) constituted 5.5% (about 
1 million) of CVD deaths in 2013.[3] 
Epidemiological data have indicated 
that SSA has a disproportionately 
high CVD mortality burden.[4,5]    
In Rwanda, particularly, CVDs 
ranked third of the most common 
cause of death in 2012 accounting 
for 8% of deaths [6], and ranked 
second of the most common cause 
of death in 2016 accounting for 14 
% of deaths.[7] These ranks of CVDs 
on proportional mortality in 2012 
and 2016 confirm how CVDs should 
be among public health issues that 
need special attention in Rwanda.    
In Rwanda, as it should be in SSA 
countries and other LMICs, urgent 
action is needed to lower the 
aforementioned CVD mortality 
burden. One of the strategies to 




achieve this goal (lowering CVD 
mortality burden), as it has been a 
case in developed countries, is to 
ensure early detection and 
treatment of individuals at risk. 
Lipid-based (L-B) techniques were 
initially developed, tested and 
applied to determine individual and 
absolute CVD risk prediction in 
developed countries.[8,9]These 
laboratory techniques were 
perceived to be costly in extent to 
which settings with limited 
resources could not apply them 
consistently and thus researches 
were conducted to develop BMI-
based (BMI-B) algorithms, perceived 
cost-effective compared to L-B 
algorithms vis-à-vis determining 
CVD risk prediction and 
characterization.  
The Framingham laboratory based 
equation (termed L-B equation in 
this paper) is one of the famous 
tools used to determine sex specific 
CVD risk prediction with use of 
eight CVD risk factors: Age, Total 
Cholesterol (T-C), high dose 
lipoprotein cholesterol (HDL_C), 
Systolic blood pressure (SBP), blood 
pressure (BP) treatment, smoking, 
and diabetes.[8] Afterwards, the 
Framingham non laboratory-based 
equation (termed BMI-based 
equation in this paper), which 
substitute body mass index (BMI) 
for T-C and HDL-C   was developed 
and validated among African 
Americans.[10] As the BMI-based 
equation does not require laboratory 
information, it is cost effective 
compared to lipid-based equation; 
reason why it has been 
recommended to be used, especially 
in resource-limited settings.[10,11] 
More studies were conducted to 
compare BMI-B equation to different 
L-B equations and the results have 
indicated that there is positive 
correlation in CVD risk prediction 
and concordance in CVD risk 
characterization between lipid and 
BMI based equations.[11,12]  
However, all studies have 
recommended doing more studies in 
LMICs in order to evaluate the 
comparability of lipid and BMI-
based algorithms.  
On the best of our knowledge, 
neither approach utilizing lipid-
based algorithm nor BMI-based 
algorithm was used in Rwanda to 
predict CVD risk in the community. 
BMI-based tool is the most 
accessible in resource-limited 
settings. In Rwanda, there is no 
intervention that has been initiated 
to screen individuals for high CVD 
risk using either BMI-based or lipid-
based tool. This underpins a need to 
assess the comparability of both 
tools in predicting cardiovascular 
risk (CVR) to inform decision 
makers on which cost-effective tool 
could be used to identify individuals 
at high CVR for early treatment, 
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prevention and reduction of CVD 
burden among Rwandan population. 
Thus, the objective of this study was 
to assess the comparability of L-B 
and BMI-B tools in predicting CVD 
risk score and characterizing CVD 
risk by conducting secondary 
analysis.     
Materials and methods 
 
Type of study and data source 
We conducted a secondary analysis 
of World Health Organization 
Stepwise approach to NCD 
surveillance (WHO STEPs) subset of 
data collected during the NCDs risk 
factors population-based survey 
completed in 2013 in Rwanda. The 
survey was a cross-sectional survey 
and the participants were between 
15 and 65 years old. The general 
research methodology, ethical 
considerations and results for the 
first NCD risk factors survey are 
described elsewhere.[13] 
Access to STEPs dataset was 
authorized and provided by Rwanda 
Biomedical Centre (RBC), a policy 
implementing agency of Rwanda 
Ministry of Health. The primary 
survey included 7240 participants.  
During the data cleaning, we 
omitted study participants with 
missing data and non-response on 
any key variables to be used in 
calculation of individual total CVD 
risk score for both lipid and BMI 
based equations, and 6613 study 
participants remained. From the 
6613 participants, we excluded 
those below 30 years old as the 
lipid-based CVD risk scoring tool 
(Framingham heart Study) was 
established based on a population of 
30 years old and above. A total of 
4185 was included in the final 
dataset to determine an individual 
and absolute total CVD risk score 
using both lipid-based and BMI-
based equations.    
 
Individual-levels absolute CVD risk 
scores were calculated using both 
tools taking into consideration self-
reported data (sex, age, diabetes, 
high blood pressure treatment, and 
current smoking status), 
anthropometric measurement data 
(height, weight, calculated body 
mass index and systolic blood 
pressure), and laboratory data (total 
cholesterol; T-c and High Density 
Lipoprotein-C: HDL-c). The lipid-
based (L-B) algorithm tool provides 
10-year cardiovascular risk score 
basing on age, T-c, HDL-c, systolic 
blood pressure and high blood 
pressure treatment. The BMI-based 
algorithm provides the 10-year 
global cardiovascular risk score 
using all variables in lipid-based 
algorithm except T-c and HDL-c 
which are replaced by the BMI. It is 
to note that in primary data we had 
three SBP readings, and in this 
169 




secondary study the average 
between the second and third SBP 
readings was calculated and 
considered as the real SBP for 
included participant.  The variable 
of diabetes, in present study, 
encompasses both newly diagnosed 
and reported cases. With reference 
to the WHO standards,[14] the 
newly diagnosed diabetes was 
confirmed when fasting blood 
glucose is ≥ 7mmol/l (126mg/dl).  
 
To calculate the individual global 
CVD risk scores , we used the 
formulae employed by D’Agostino et 
al: [15]   CVD risk score = 1-
So(t)exp(ΣßiXi – AvgRisk)  ,   where: 
 So(t) is the baseline survival 
at follow-up time t (here t=10 
years) as determined in the 
Framingham Heart Study,   
 ßi is the estimated regression 
coefficient as determined in 
the Framingham Heart Study, 
 Xi is log-transformed value of 
the ith risk factor as provided 
in dataset of the first NCDs 
risk factors survey,  
 
 AvgRisk is an average risk as 
determined in the initial 
Framingham Heart Study. 
Because of time and financial 
constraints to conduct a 10-years 
cohort study we used So(t), βi and 
AvgRisk as determined in the 
Framingham heart study and their 
respective values are provided per 
gender (sex) and per type of 
algorithm in the Table 1. However, 
we acknowledge that there exists a 
difference between population from 
Framingham heart study and 
Rwandan population and thus the 



























Table 1. So (10), AvgRisk and βi per type of gender (sex) and per algorithm 
(separately)

















  So (10) 0.95012 0.88936 
AvgRisk 26.1931 23.9802 
β for age 2.32888 3.06117 
β for total cholesterol  1.20904 1.12370 
β for HDL cholesterol  -0.70833 -0.93263 
β for SBP if not treated  2.76157 1.93303 
β for SBP if treated 2.8226 1.99881 
β for Smoking  0.52873 0.65451 

















So (10) 0.94833 0.88431 
AvgRisk 26.0145 23.9388 
β for age 2.72107 3.11296 
β for BMI 0.51125 0.79277 
β for SBP if not treated 2.81291 1.85508 
β for SBP if treated  2.88267 1.92672 
β for Smoking  0.61868 0.70953 
β for Diabetes  0.77763 0.53160 
So (10): Baseline survival at follow-up time t (t=10 years), AvgRisk: Average risk, ßi: 
Regression coefficient, HDL: High Density Lipoprotein, SBP: Systolic Blood Pressure, BMI: 
Body mass index 
  
Statistical analysis  
 
Box plot and histogram were used to 
assess the distribution of 
continuous variables, and 
descriptive statistics were used to 
describe the included participants.   
The mean (± standard deviation) was 
used to present normally distributed 
continuous variables, otherwise the 
median (25th-75th percentiles) was 
used. Categorical variables were 
presented in both absolute 
frequencies and percentages. To 
compare men and women vis-à-vis 
CVD risk factors (variables) 
considered to calculate CVD risk 
scores for both algorithms (L-B and 
BMI-B), Pearson’s Chi-squared (χ2) 
and Student’s t-tests were used for 
categorical and continuous 
variables, respectively. Wilcoxon 
rank-sum test was applied for 
continuous variables with 
asymmetric distribution. 
Homoscedasticity was assessed 
using Levene’s test and Fmax test 
before conducting Student’s t-test 
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for continuous variables with 
symmetric distribution.  
 
Spearman rank’s correlation 
coefficient was used to assess the 
correlation between the BMI-based 
algorithm and lipid-based algorithm 
in determining a 10-year CVD risk 
score.  Scatter plots were used to 
present the correlation between the 
two types of individual CVD risk 
scores. As indicated in one of the 
previous comparative studies,[16] 
CVD risk was categorized as:  <10% 
low risk, [10% - 20%[ moderate risk 
and ≥20 % high risk.  The percent of 
study participants equivalently 
characterized as ‘high’, ‘moderate’ or 
‘low’ risk was determined in the 
present study for the lipid-based 
and BMI-based equations of the two 
CVD risk scores. Statistical testing 
procedures for Cohen’s Kappa were 
conducted to test the level of 
agreement between these two 
algorithms in ranking study 
participants in three categories of 
CVD risk.  All statistical analyses 
were performed using Stata 13 
(Stata Corporation, College Station, 
Texas, USA); and significance 
testing was performed at 5%.  
Ethical considerations 
The Institutional Review Board at 
Rwanda Ministry of Health, known 
as Rwanda National Ethics  
Committee (RNEC), evaluated the 




1.Input cardiovascular risk 
variables 
A total of 4185 participants were 
included for the analysis, among 
which 2657 (63.5%) were women. 
The median age (years), total 
cholesterol (mg/dl) and the mean 
BMI (Kg/m2) among women are 
significantly higher compared to 
those of men (see Table 2). The 
mean SBP (mmHg), the prevalence 
of reported smoking for men is 
significantly higher compared to 
that of women (see Table 2).  Median 
HDL cholesterol is significantly 
lower in men than in women. 
Reported hypertension treatment 
rate was similarly low in men and 
women, and the prevalence of 
diabetes is statistically the same 














Table 2. Input CVR variables and gender  
Characteristic  Total  (N= 4185) Men (n=1528) Women (n=2657)  P-value 
Age, median 
(P25-P75)  









39.8 (30.5- 52.2) 37.5 (29.0-50.3) 41.0 (31.7-53.0) <0.001* 
SBP (Mean, 
SD), mmHg 
124.06 (17.51) 124.98 (15.51) 123.53 (18.55) 0.010* 
BP treatment, 
n (%) 
29 (0.7) 6 (0.4) 23 (0.9) 0.076 
Smoking, n 
(%) 




diabetes, n (%) 
71 (1.7) 26 (1.7)  45 (1.7)  0.985 
BMI (Mean, 
SD) 
22.64 (4.39) 21.86 (4.79) 23.09 (4.08) <0.001* 
HDL: High Density Lipoprotein, SBP: Systolic Blood Pressure, BP: Blood pressure, BMI: Body 
Mass Index, *Statistical significance between men and women (P-value ≤ 0.05) 
 
1.Gender and 10 year CVR score 
prediction using BMI and Lipid 
based tools 
Both tools found that men are at 
high risk to develop cardiovascular 
event at 10 years. The median (25th-
75th percentiles) 10-year absolute 





BMI-based and lipid based tools 
among men are significantly greater 
compared to women; 5.09 % (2.8-
10.33) vs 2.48 % (1.36-5.24) with p-
value < 0.001 and 3.61 % (1.98- 
7.26) vs 1.86 % (1.07-3.75) with p-
value < 0.001, respectively (See 

















A 10-year CVD risk score  
prediction  by BMI-based 











A 10-year CVD risk score  
prediction by lipid-based 









 *Indicates statistical significance between men and women, BMI: Body Mass Index  
 
Although, the proportions of study 
participants classified in moderate 
and high 10-years CVR 
(cardiovascular risk) are 
significantly higher among men 
compared to women as per the 
prediction by both lipid-based and 
BMI-based tools, BMI-based 
algorithm seems to detect more 
people at moderate and high risk 
than lipid-based algorithm 























Table 4. Characterization of Study Participants into three Categories of 
CVD Risk 
  












(%)     
Low risk1 3,537 (84.5) 1,132 (74.1) 
 
2,405 (90.5) <0.001 















(%)    



















* indicates statistical significance between men and women, 1: low risk: <10%, 2: 
Moderate risk: 10-19.9%   3: High risk: ≥20% 
 
1.Agreement between BMI and Lipid based CVR scoring tools to predict a 
10-year CVR score 
There is a strong positive correlation between Lipid-based and BMI-based- 
algorithms in predicting a 10-year CVD risk score in overall participants, 
women and men (see  
 
Figure of scatterplots) with spearman rank correlation coefficients (SRCC) of 
0.9380, 0.9086 and 0.9399, respectively (all p-values for the SRCC were 


























Figure of scatterplots: Scatter plots indicating the performance of BMI-
based tool vs Lipid-based tools 
 
A: Scatter plot for overall study participants; B: Scatter plot for men; C: Scatter 
plot for women, BMI: Body mass index  
 
The observed agreement between 
the two algorithms was at 89.3% 
with kappa statistic of 0.52 (P-value 
<0.001). When we computed kappa 
statistic for men only and women, 
one at a time, we found that the 
observed agreement was at 82.9% 
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with kappa statistic of 0.52 (p-
value<0.001) and 93.1% with kappa 
statistic of 0.48 (p-value<0.001), 
respectively. Thus, the agreement 
found between L-B algorithm and 
BMI-B algorithm in determining 
CVD risk score for three cases is 
moderate, as three kappa statistics 
are in the range of 0.41-0.60,[17] 
and is statistically significant (P-
value <0.001).  The reason for the 
discrepancy between the unadjusted 
level of agreement and kappa found 
in this study is that high CVD risk 
is a rare observation. 
Discussion 
Cardiovascular diseases are among 
the first causes of morbidity and 
mortality globally but mostly in 
LMICs. Early detection and 
treatment of individuals at high CVR 
may alleviate the burden caused by 
CVD. Finding a most accessible and 
cost-effective tool to predict CVR is 
an essential solution in LMIC. In 
this study, we assessed the 
similarity of lipid-based and BMI-
based models in predicting the total 
risk to develop cardiovascular 
disease.  
 
Gender distribution of traditional 
cardiovascular risks varies globally 
depending on studied 
population.[18] In the present study, 
we found that men were at high 
cardiovascular risk than women 
using both lipid-based and BMI-
based tool (Table 3). This indicates 
that both the two tools have 
tendency of predicting CVD risk 
score in the same direction. This 
finding corroborates with other 
existing evidence.[19]  This may be 
helpful in prevention and health 
education strategies.  
  
The median (25th-75th percentiles) 
estimated 10-year CVD risk score to 
the overall participants in this 
study, 3.27% (1.72-6.93) for BMI-
based algorithm and 2.37% (1.28-
4.95) for lipid-based algorithm are 
quite lower than those estimated in 
the study conducted among 
Ghanaian migrant and home 
populations. In the latter study, 
estimated median (25th-75th 
percentiles) was 9.5% (5.4-15.7) for 
Framingham non-laboratory (BMI-
based) algorithm and 7.3% (3.9-
13.2) for Framingham laboratory 
(lipid-based) algorithm.[20] This 
difference may be due to the 
difference in CVD risk factors profile 
between two study populations; 
CVD risk factors profile of Ghanaian 
population [20] indicates that 
unhealthy lifestyles and metabolic 
risk factors for CVDs (not reported 
here) are more prevalent among 
Ghanaian population than among 
Rwandan population (Table 2).     
 
 Even though laboratory-based CVD 
risk assessment is taken as a gold 
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standard[11], we found that the 
proportions of study participants in 
high and moderate CVD risk 
categories are higher for non-
laboratory based algorithm 
compared to laboratory based 
algorithm, for both men and women. 
These findings corroborate with the 
study conducted in Ghana, an 
African country, where it was found 
that the non-laboratory equation 
ranked almost 1.5 times more 
people at high absolute 10-year CVD 
risk than did the laboratory 
equation.[20] These findings are 
consistent with the study of Pandya 
and his colleagues who found that 
the non-laboratory-based risk score 
similarly characterized high and low 
risk men and women compared to 
the Framingham function.[11] This 
finding may be taken as an 
advantage of using the BMI-based 
tool in the community with a 
referral guideline to health facilities 
for confirmation and treatment. It 
would be a concern if BMI-based 
tool has underestimated the CVR 
prediction. 
 
When we assessed the correlation 
between lipid-based algorithm and 
BMI-based algorithm to predict a 
10-year CVD risk for men, women 
and overall study participants, we 
found that there is a positive 
correlation for all cases (the 
spearman rank correlation 
coefficients  > 0.90) and is 
statistically significant (p<0.001).  
This level of correlation is 
considered a very high correlation as 
in all cases (overall study 
participants, men only and women 
only) spearman rank correlation is 
greater than 0.90.[21] The results 
from the correlation assessment are 
not far from the results found in 
other comparative studies 
conducted to compare laboratory-
based risk score to non-laboratory-
based risk score and found that the 
Spearman rank correlation 
coefficients is greater than 
0.90.[11,12,22] With these findings, 
it may be assumed that BMI-based 
and lipid-based algorithm are 
comparable in CVD risk score 
prediction, irrespective of the 
settings. However, more studies are 
needed in the settings where such a 
study has not yet been conducted 
on the comparability of the two 
tools.   
 
Furthermore, we computed kappa 
statistics to assess an agreement 
between BMI-based algorithm and 
lipid-based algorithm, and found 
that there is a moderate agreement 
between two tools as kappa statistic 
equals 0.52 (P-value <0.001), 0.52 
(p-value<0.001) and 0.48 (p-
value<0.001) considering overall 
study participants, men only and 
women only, respectively. However, 
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the kappa statistics, found in this 
study, is lower than the one found 
in the study [20] when Framingham 
laboratory and non-laboratory based 
tools were compared, kappa 
statistics was 0.63.  This difference 
may have resulted either from study 
design of current study (cross-
sectional) which is different from the 
study design of Framingham heart 
study (cohort study) or difference 
between study populations in 
various aspects of life. In availability 
of (financial) resources, a cohort 
study used in Framingham heart 
study would be ideal to exactly 
quantify and confirm the reason 
why kappa statistics found in this 
study are lower than the ones found 
in the study conducted by Daniel et 
al. [20]    
 
Study limitation 
Even though the dataset from which 
the study participants were drawn 
was designed in  such a way as to 
be representative of the Rwandan 
population, the sample of this study 
might be not quite representative of 
the Rwandan population due to the 
eligibility criteria. The sample 
excluded study participants below 
30 years of age, participants with 
missing data and non-response on 
any key variables required to 
calculate the individual total CVD 
risk score for both lipid and BMI 
based equations. Despite this 
limitation of the incompleteness / 
non response, further investigation 
indicated that incompleteness is not 
participants’ gender or age 
dependent (results not shown here), 
thus we assume that the 
incompleteness is missing 
completely at random (MCAR). This 
implies that the results of this study 
are unbiased.  In addition, diabetes 
diagnosis was based on fasting 
blood glucose or history of diabetes 
in a setting where the screening of 
diabetes is not routinely done.  
However, the criteria for diabetes 
status was the same for both tools. 
Waist circumference (WC) is not 
considered in both tools while high 
WC reflects visceral fat 
accumulation which is prone to 
cause cardiovascular events in 
LMICs.[23]    
In this study, even though CVD risk 
scores were not calculated from 
actual or updated data because of 
time and financial constraints to 
conduct a 10-year cohort study, the 
present findings can be used as a 
baseline of further studies assessing 
comparability of both BMI-based 
and lipid-based algorithms in 
predicting individual CVD risk 
score.   We also acknowledge the 
difference between population from 
Framingham heart study and 
Rwandan population, and thus we 
recommend, in availability of 
financial resources and time, to 
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conduct a 10-year or 5-year cohort 
study to determine an accurate CVD 
risk core.  
Conclusion  
 
BMI-based and lipid-based 
algorithms agree satisfactorily and 
highly correlate in predicting the 
total 10-years cardiovascular risk in 
Rwanda. As stated from other 
works, BMI-based algorithm should 
be used in situations with limited 
resources where laboratory facilities 
are inaccessible. In Rwandan 
specific context, we recommend its 
use at the community level with 
referral guideline; however, there is 
need to evaluate how easy it is to be 
used by community health workers. 
There is gender disparity in 
cardiovascular risk characterization; 
men being at higher risk than 
women. Further studies to 
understand this gender disparities 
and determinants of high 
cardiovascular risk are needed to 
contextualize interventions.  
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